Wird geladen...
Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools
BACKGROUND: Glioblastoma (GBM) is a highly aggressive primary brain tumor. Currently, the suggested line of action is the surgical resection followed by radiotherapy and treatment with the adjuvant temozolomide, a DNA alkylating agent. However, the ability of tumor cells to deeply infiltrate the sur...
Gespeichert in:
| Veröffentlicht in: | Cancer Rep (Hoboken) |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941428/ https://ncbi.nlm.nih.gov/pubmed/32729241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1220 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|